Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Genetic Research » Selecting Human Embryos for Height, IQ Based on Polygenic Scores Won't Work Well, Study Suggests

Selecting Human Embryos for Height, IQ Based on Polygenic Scores Won't Work Well, Study Suggests

Oct 18, 2019
|
Julia Karow

HOUSTON – Polygenic scores derived from large genome-wide association studies can at least partially explain the variability seen in complex human traits, such as height or cognitive ability. Combined with the ability of preimplantation genetic testing to scan the entire genome of a human embryo, this has raised the specter of "designer babies" where prospective parents choose embryos based on traits they find desirable.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Mar
16
Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Sponsored by
Bio-Rad

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community. 

Mar
23
Featured Webinar

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Colorectal Cancer

Sponsored by
Roche

This webinar will discuss findings from the study, in which molecular residual disease (MRD) was assessed using circulating tumor DNA (ctDNA) without prior mutational knowledge in oligometastatic colorectal cancer (CRC) patients who had received neoadjuvant chemotherapy. This study also investigated urine as an alternative analyte for ctDNA MRD detection.

What's Popular?

In Genetic Research

  1. Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test

  2. Glaucoma GWAS Meta-Analysis Uncovers New Risk Loci, Shared Risk Across Ancestry Groups

  3. Multiple Myeloma Therapy Targets, Resistance Pathways Identified With Single-Cell Sequencing

  4. Population History of East Asia Unveiled in Genomic Study

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.